fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://trulaw.com/wp-content/uploads/2025/11/Symptoms-and-Characteristics-of-NAION.webp)
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://pharmacally.com/wp-content/uploads/2026/01/Semaglutide-NAION.png)
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cf2/12270588/2c0f4558a2d2/dmj-2025-0242f2.jpg)
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://www.aaojournal.org/cms/10.1016/j.ophtha.2026.02.013/asset/a84e8afc-cbcb-4912-9601-ff30c1d0d7b9/main.assets/gr3_lrg.jpg)
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://ars.els-cdn.com/content/image/1-s2.0-S305130732500001X-ga1.jpg)
![fda safety communication semaglutide vision loss naion 2025 Recent studies have begun to explore a possible link between GLP-1 receptor agonists (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic optic neuropathy ( Ozempic Blindness Lawsuit [2026 Guide]](https://www.torhoermanlaw.com/wp-content/uploads/2024/09/GLP-1-Vision-Loss-MDL-3163.jpg)

























